{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-005092","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.131565+00:00","generated_at":"2026-06-18T21:49:43.267769+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Arcadia Biosciences implements 1-for-40 reverse stock split effective March 1, 2023","bullets":["Reverse stock split of common stock at 1:40 ratio, effective 12:01 a.m. ET on March 1, 2023.","No fractional shares; odd shares rounded up to the next whole number.","Authorized shares remain 150,000,000; par value unchanged at $0.001 per share.","Stockholders approved split range (1:10 to 1:40) at Feb 15, 2023 special meeting; board selected 1:40."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-005092","json":"https://secwatch.observer/filing/0000950170-23-005092.json","markdown":"https://secwatch.observer/filing/0000950170-23-005092.md","text":"https://secwatch.observer/filing/0000950170-23-005092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/0000950170-23-005092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/rkda-20230227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:49:43.267769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b8d95c56737834a887e52a6eb80c99d8cb9974f","claim":"Arcadia Biosciences, Inc.: Approved and filed a Certificate of Amendment to effect a 1-for-40 reverse stock split of common stock (effective 2023-03-01).","evidence_excerpt":"On February 27, 2023, Arcadia Biosciences, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect a 1-for-40 reverse stock split of the outstanding shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), effective as of 12:01 a.m. (Delaware time) on March 1, 2023 (the “Reverse Stock Split”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023005092/0000950170-23-005092-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-03-01"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}